|
HS Code |
271189 |
| Generic Name | Trazodone |
| Brand Names | Desyrel, Oleptro |
| Drug Class | Serotonin antagonist and reuptake inhibitor (SARI) |
| Indications | Depression, anxiety disorders, insomnia |
| Dosage Forms | Tablet, extended-release tablet |
| Route Of Administration | Oral |
| Mechanism Of Action | Inhibits serotonin reuptake and blocks 5-HT2A receptors |
| Common Side Effects | Drowsiness, dry mouth, dizziness, headache |
| Controlled Substance | No |
| Prescription Status | Prescription-only |
| Half Life | 5-13 hours |
| Metabolism | Hepatic (CYP3A4 enzyme) |
| Pregnancy Category | Category C |
| Protein Binding | 89-95% |
| Warnings | Risk of suicidal thoughts in young adults |
As an accredited Trazodone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Trazodone comes in a white plastic bottle containing 100 tablets, labeled with dosage strength, manufacturer details, and usage instructions. |
| Shipping | Trazodone should be shipped in tightly sealed, properly labeled containers, protected from light and moisture. The packaging must comply with local, national, and international regulations for pharmaceutical products. Temperature conditions should generally be controlled (15–30°C). Handle with care to avoid breakage or contamination during transit, ensuring product integrity upon delivery. |
| Storage | Trazodone should be stored at room temperature, typically between 20°C and 25°C (68°F and 77°F). Keep the medication in a tightly closed container, away from moisture, heat, and direct light. Store it out of reach of children and pets, and do not store it in the bathroom. Proper storage helps maintain the medication’s effectiveness and safety. |
Applications of Trazodone in Industrial ManufacturingAs a manufacturer with pharmaceutical-grade synthesis and regulatory expertise, we support global partners in leveraging trazodone as a specialty raw material within several advanced industrial sectors. The following sections detail authentic downstream settings where trazodone is incorporated as an active ingredient, with a focus on compliance, process integration, dosing, and finished product applications aligned with strict 2026 quality frameworks. 1. Pharmaceutical Finished Dosage Forms – AntidepressantsPharmaceutical formulation companies source trazodone for primary use in the manufacture of oral dosage forms designed for major depressive disorder and related psychiatric indications. Active ingredient specifications follow pharmacopeial monographs and are strictly monitored through analytical batch release protocols. Manufacturers blend trazodone into tablets or capsules during high-shear granulation, followed by controlled drying and compression or encapsulation. Finished goods target international regulated markets and must pass stringent release testing and stability profiling per their product registration dossiers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Contract Development and Manufacturing Organization (CDMO) – Clinical Trial SuppliesCDMO operations depend on high-purity trazodone for both pilot-scale clinical batch manufacturing and stability study sample preparation. Formulated batches may serve ongoing global clinical trials spanning multiple regions, requiring qualification under investigational drug protocols. Formulation teams align raw material intake and dispensing with clinical protocol specifications and manage blinding requirements for active and comparator arms as appropriate for each study phase. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Veterinary Pharmaceuticals – Companion Animal Sedative FormulationsVeterinary pharmaceutical manufacturers use trazodone as an active ingredient in oral formulations for companion animal behavioral management and perioperative sedation protocols. Development teams adapt excipient systems to ensure palatability and GI absorption consistent with veterinary pharmacokinetics. Production lines employ dedicated cleaning and cross-contamination control measures to maintain animal-use traceability and batch segregation from human pharmaceutical divisions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Active Pharmaceutical Ingredient Supply – Repackaging and Compounding PharmaciesLicensed API importers and compounding pharmacies use bulk trazodone to fulfill batch reconstitution orders for hospital and specialty pharmacy chains. Compounding teams require full traceability and chain-of-custody compliance for all incoming lots, with material weighed and prepared under cleanroom ISO 7 or ISO 8 containment. Final compounded solutions or customized oral forms must match individualized prescriptions or off-label protocols authorized by licensed healthcare practitioners. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Trazodone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every pallet that leaves our production line carries years of chemical engineering, strict batch-by-batch quality checks, and safety protocols that we never compromise. Trazodone hydrochloride, in tablet or powder form, draws high attention among the pharmaceutical actives we synthesize. Decades on the manufacturing floor give us hands-on experience with its production, and we understand the precise handling and attention it demands. Our team follows every nuance, from weighing raw materials to inspecting the uniform crystalline powder that comes off the dryer, to ensure each kilogram meets the physical description and chemical identity you expect.
Trazodone’s story inside our plant always starts with careful analysis of the starting amines and other input materials. Every reaction step gets tracked by our chemists in real-time, with repeated sampling to confirm identity and measure trace impurities. Each finished batch must pass stringent in-house analysis for conformity with USP and EP monographs. Over the years, we invested in high-performance liquid chromatography and Fourier-transform infrared spectroscopy to sharpen our batch consistency and minimize cross-contamination. Relying on analytic discipline makes a bigger difference than any glossy specification sheet could show; even the best raw materials can falter without close attention during reaction and drying.
Model specification for trazodone from our synthesis line aligns with the standards set in global pharmacopeias. Chemically, it presents as C19H22ClN5O, with trace water contents tightly monitored to prevent physical instability. API purity in our lots lands above 99%, with residual solvents and related substances always tested below approved limits. Water content, by Karl Fischer titration, remains under 1%. We focus on particle fineness and flow properties because these traits affect downstream tableting and blending in customer plants. Tablets reach customers at specified strengths—frequently 50 mg, 100 mg, or 150 mg—ensuring predictable performance in formulation. Each lot gains a unique batch certification from our qualified laboratory, documented with both HPLC chromatograms and impurity profiles.
Reliable product consistency comes from technical rigor rather than routine. Each batch faces a detailed release protocol with potency, identity, and impurity checks. Rigorous oversight over drying, blending, and tableting prevents formulation setbacks in customer factories. Even process water gets daily quality tests, since even small mineral or organic contamination could compromise the outcome. We do not cut corners—this commitment wins trust with long-time buyers who cannot afford failed formulations or unpredictable stability.
Trazodone earned its position as an active pharmaceutical ingredient through demonstrated effectiveness in managing mood disorders. Downstream manufacturers count on our purity and sequence integrity to support consistent tablet dissolution and reliable therapeutic action. While clinical settings often focus on human health outcomes, from our vantage point, patient safety means a spotless record for purity, identity, and stability. Our role supports not just patient recovery but the peace of mind of hospitals, compounding pharmacies, and contract manufacturers who stake reputations on every bottle.
We ship traceable lots to generics producers in high-volume regions and to smaller custom formulators. Some work in high-speed continuous production, where powder flow and compressibility mean smoother shifts and fewer interruptions. Others run pilot batches for reformulated tablets or experimental markets, and they value the documentation on impurity profiles, shelf life, and compressibility that comes with each shipment. Our own team works closely with their technicians, troubleshooting downstream issues if they arise and sharing advice for optimal processing.
Put trazodone side by side with other antidepressant APIs and the chemical differences become clear as day. Its structure—a triazolopyridine compound—sets it apart from selective serotonin reuptake inhibitors or tricyclic antidepressants. From a manufacturing perspective, this chemistry demands different solvents, catalysts, and protective atmospheres throughout the cascade of reactions. For example, the heterocycle formation step must hit precise reaction temperatures to avoid by-product formation, unlike more robust tricyclic intermediates. Our staff have learned these conditions through trial and error, tuning process parameters until yields and purity reach commercial scale requirements. Process waste is minimized, an ongoing benefit to plant safety and environmental compliance.
Beyond the molecule itself, trazodone’s physicochemical properties differ from bulkier tricyclics or sulfur-containing antidepressants. Our manufacturing technicians adjust crystallization protocols, solvent drying rates, and even packaging methods because trazodone is more sensitive to humidity than many similar APIs. Delivered product stability relates directly to our control over these fine points. Our in-house stability chambers run real-time and accelerated aging stock for each lot, with multiple samplings to verify ongoing product robustness not just at release but through to patient use.
For all the talk of automated manufacturing, hands and eyes remain critical at our facility. Old-timers remember when a minor miscue in crystallization could spoil an entire batch, wasting weeks of careful preparation. Even today’s sensors and electronic logs still get paired with ground-level double checks. We employ dedicated plant chemists whose job includes taste tests, olfactory checks, and continuous records of batch color and texture.
Mistakes can set off ripple effects into downstream health. Quality here is not a slogan, but a daily practice guided by exact science and factory realism. We see every deviation—unexpected hues, off-spec granulation, or odd odor signatures—as an urgent signal for full process review, not something to gloss over. Years of experience tell us that patient safety links directly to the manufacturing pride and responsibility upheld by our frontline team.
Nobody cuts corners on compliance if they plan to stick around in chemical manufacturing. With trazodone, that starts with factory entry: GMP audits, validated cleanrooms, secure raw material storage, and shut-off valves checked by our engineering department every shift. Hazard analysis and critical control points (HACCP) maps outline every risk, backed by live monitoring of temperature and pressure. Chain-of-custody documentation starts from raw material intake and spans every weigh, filtration, drying, and tableting step. These records prove invaluable in trace investigations or audits.
For customers aiming at European, US, or Japanese regulatory markets, demonstrating full traceability and batch verification never happens by accident. Our team leads annual reviews of cleaning protocols, cross-trains for emergency response, and adopts the latest reporting standards—without waiting for new regulations to force an upgrade. Years of zero major findings in health authority inspections encourage confidence, but it’s day-to-day diligence that keeps our license running and our name respected.
Suppliers without up-to-date feedback fall behind in this business. We keep our ears open to technical questions from customer formulators. Common topics include reactivity with specific excipients, long-term stability in global shipping scenarios, or granulation behavior in direct compression lines. In response, we invest in more robust packaging—aluminum barrier liners, vacuum sealing, and desiccant-assisted pouches. Outbound products ship with certificate-of-analysis packets including detailed impurity maps, water content, and particle size analysis. This approach means stability-related recalls remain remote events, not commonplace headaches.
We also provide supplemental technical support for new entrants and established clients alike. If a new tableting issue crops up at a customer facility, production chemists at our end help dissect the possible source. During partnership reviews, we listen for signs of shifting market preference—like the rise in fixed-dose combination requests—and keep our process flexible for quick response. In the long run, this honest dialogue trims cost for everyone and maintains a steady supply line in volatile global conditions.
Consistent trazodone output relies heavily on raw material quality. Even minor supplier changes upstream risk byproduct increases or yield drops. Bulk amines and precursor intermediates require certified analysis, with our own incoming quality checks backing up vendor documents. If a flag shows up at our gate, the lot is segregated for further testing.
Solvent management takes up a large part of our environmental compliance efforts. Our process produces streams of organic and aqueous waste. We invested in on-site solvent recovery and distillation. Recycled solvents reach purity targets set by our lab before reintroduction. Continuous monitoring of emissions, and regular cleaning of process equipment, reduce downtime and prevent uncontrolled releases.
Industry advances mean that many molecules remain stable for years—if handled right. Our packing department adopts nitrogen-flush systems and opaque, high-barrier liners, sealing each drum or tote to keep moisture away. Preprinted batch labels include full trace data back to synthesis and packing. We routinely perform shelf-life extension studies, pulling samples under various conditions and retesting for potency, impurity counts, and water content. This practical focus on downstream storage and shipment helps customers in hot, humid, or variable climates avoid stability failures. Our experience in global markets and feedback from returned samples let us keep improving storage technology.
Every shipping case meets international codes for hazardous and pharmaceutical goods. Our warehouse maintains strict HVAC monitoring to prevent ambient moisture from creeping into finished stocks. We send regular updates to major buyers if best practices change or new packaging formats show improved outcomes.
Some clients ask if producing trazodone compares to well-known SSRIs like fluoxetine or paroxetine. Our answer is practical: every chemical demands optimized conditions. Trazodone’s triazolopyridine base resists hydrolysis better than some SSRIs but suffers more in humid conditions post-synthesis. We tweak crystallization and drying with every lot, using gas-tight dryers and gentle vacuum. Other antidepressants with sulfur groups may need oxidation-resistant materials for stirring and holding; we don’t see this with trazodone, which keeps maintenance and equipment replacement costs lower for us.
Formulation teams working with multiple antidepressants notice that trazodone flows better as a fine, crystalline powder than waxy or oily bases required for certain others. Fast, predictable dissolution helps downstream operators in tableting rooms avoid sticky batches, uneven blending, or compressibility failures. As manufacturers, our focus stays fixed on the process details that show up in the customer’s final quality assurance report.
Chemical plants delivering both endpoints—active ingredients and tablets—hold a strong position in today’s market. This integration allows us to test every process change in both synthesis and finished drug form. Vertical workflows shorten performance feedback loops, making it easier to spot outliers in dissolution rate, shelf life, and impurity growth. We learn what works best for downstream blending by tracing how slight shifts in crystallization or drying impact batch tableting efficiency. Pharmaceutical partners count on this transparency, since fewer steps separate their own quality checks from our factory records.
Several larger generics companies send tech teams to observe our approach and share their own operational data. Over time, these collaborations raise industry standards. We lead joint improvement projects—tracking moisture, blending time, or reactivity data. Our lab can quickly modify a production step to accommodate an evolving market demand, such as modified-release forms or taste-mask coatings. This agility, fine-tuned by field experience, gives us a nimble edge in regulatory audits and customer service.
Earning trust in this field takes more than certifications. Hospital buyers and supply chain managers base critical purchasing decisions on batch reliability and recent customer service data. We take pride in years spent delivering without recalls or reportable failures linked to our in-house trazodone. Quality assurance provides certificates for every shipment, and our regulatory team logs near misses and field complaints in a digital system accessible by authorized customers. That’s not just compliance—it’s operational accountability.
Transparency also means owning up to mistakes. In rare cases where out-of-specification results crop up during internal review, shipments stop, customers receive notice, and corrective action follows before fresh production begins. This culture, built over years, boosts supply chain security for the hundreds of hospitals, clinics, and pharmaceutical compounding labs depending on our lines.
Markets keep evolving, and we keep investing in plant upgrades, safety features, and analytic equipment. Regulatory rules drift and sharpen; we track changes, revalidate processes, and adopt new safety limits well before they turn into headlines. Demand for higher-value drug combinations, novel delivery systems, and advanced analytical verification grows each year. Feedback from end-users about packaging, labelling, or document clarity gets immediate review, often leading to real-time improvement. Our teams spot emerging risks—whether in raw material sourcing, unplanned downtime, or regulatory hurdles—and respond with targeted investment.
Continuous education for both chemical operators and laboratory analysts remains a founding value. We run annual retraining on safe handling, regulatory updates, and analytical technology, using both external consultants and hands-on instruction. These efforts put our staff ahead of field trends and let them intercept warning signs in both plant and regulatory contexts before they escalate.
Nothing in chemical manufacturing compares to the satisfaction of seeing our product on a pharmacy shelf or in a laboratory inventory list. Years of accumulated operational wisdom shape every lot, and each kilogram moving through our lines tells a story our whole plant feels invested in. By focusing on technical rigor, transparent communication, and hands-on collaboration with our customers, we aim to deliver not just compliance, but confidence at every handoff within the supply chain.
For every new application, regulatory update, or market challenge, we stay ready to support formulation teams, regulatory groups, and downstream quality officers. Feedback from each product cycle translates directly to improved yield, minimized risk, and a smoother journey from synthesis to finished dose.
Daily hard work, smart engineering, and a little humility keep the doors open and shipments moving. That’s the role we play—from our first beaker of precursor to the last drum out the warehouse door—producing trazodone with pride, purpose, and experience shaped by real-world demand.